Physician profile
Cathryn Freeman
NPI 1841702651
$1,899.50
in general payments reported to CMS, 2019-2025
8 companies · $182 in 2025
The $182 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $21.65 · 2023: $121 · 2024: $1,574 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $914 · Honoraria: $575 · Food and Beverage: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $914.25 |
| Honoraria | $575.00 |
| Food and Beverage | $388.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| National Marrow Donor Program | $1,489.25 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $189.42 | 2023-2024 | Cuvitru, Hyqvia |
| Incyte Corporation | $124.99 | 2025 | Jakafi, Niktimvo |
| Emmaus Medical, INC. | $21.65 | 2022 | |
| Merck Sharp & Dohme LLC | $19.39 | 2025 | Prevymis |
| Jazz Pharmaceuticals INC. | $19.22 | 2025 | |
| Alexion Pharmaceuticals, INC. | $18.67 | 2025 | Ultomiris |
| Fennec Pharmaceuticals, INC. | $16.91 | 2023 | Pedmark |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cathryn Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.